Skip to content

Non-invasive brain stimulation and rehabilitation training

Establishment of a novel rehabilitation treatment for gait disorders in central nervous system diseases

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042230011
Enrollment
240
Registered
2023-04-20
Start date
2023-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological diseases

Interventions

Gait practice is performed while applying electrical stimulation such as tDCS (transcranial direct current stimulation) and tACS (transcranial alternating current stimulation). Stimulating electrodes

Sponsors

Ueki Yoshino
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with established diagnosis of Parkinson's disease and Parkinson's syndrome (progressive supranuclear palsy, basal ganglia cortical degeneration, dementia with Lewy bodies, multiple system atrophy, cerebrovascular parkinsonism, normal pressure hydrocephalus, etc.), corticospinal tract disorder (stroke, encephalitis, etc.) and cerebellar ataxia (spinocerebellar degeneration, etc.) by the Department of Neurology 2.Age: 40-90 years old 3. Persons who can walk on the floor or treadmill using free hands or handrails 4.Patients who have obtained written consent for participation in this study from the patients themselves or their surrogates

Exclusion criteria

Exclusion criteria: 1.History or complication of other neuropsychiatric disorders 2. If you have metal such as a clip in your skull 3. Have a cardiac pacemaker 4. Has a history of epilepsy 5.History of limb joint or spine surgery 6. Cardiovascular and respiratory diseases such as myocardial infarction, angina pectoris, hypertension, deep vein thrombosis, chronic respiratory failure, etc. and at risk for exercise 7. Having metals in the body that cannot be confirmed as non-magnetic, such as nerve stimulators, aneurysm clips, insulin pumps, stents, intraocular metals, etc. 8. If you have severe hearing impairment and are unable to communicate 9. Pregnant women, those who may be pregnant 10.In addition, if the researcher or co-investigator judges it to be inappropriate

Design outcomes

Primary

MeasureTime frame
Comparison of gait function (gait speed and gait variability) between brain stimulation and sham stimulation interventions

Secondary

MeasureTime frame
1.MDS-Unified Parkinson's Disease Rating Scale 2.Quantitative values of motor cortex excitability using TMS and surface electromyography 3.Correlation of functional connectivity between regions of the movement-related network using resting-state fMRI 4.Body movement measurement value 5.Electrophysiological assessment

Contacts

Public ContactYoshino Ueki

Mirai Kousei Hospital, Nagoya City University School of Medicine

yueki@kuhp.kyoto-u.ac.jp+81-52-704-2345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026